Jonathan David Schwartz

Insider Reports History

Location
New York, NY
Signature
/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan David Schwartz:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Chief Science & Gene Therapy Officer Stock Option (Right to Buy) 119,682 $1,800,017 $15.04 11 Feb 2025 Direct
ROCKET PHARMACEUTICALS, INC. Chief Science & Gene Therapy Officer Common Stock 299,064 $892,107 $2.98 18 Nov 2025 Direct
Tabula Rasa HealthCare, Inc. Director Common Stock 0 $10.50 03 Nov 2023 Direct

Insider Reports Filed by Jonathan David Schwartz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCKT ROCKET PHARMACEUTICALS, INC. 18 Nov 2025 1 -$7,592 4 Chief Science & Gene Therapy Officer 20 Nov 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 08 Sep 2025 1 $0 4 Chief Medical & Gene Therapy Officer 09 Sep 2025, 16:15
RCKT ROCKET PHARMACEUTICALS, INC. 18 Aug 2025 2 -$7,561 4 Chief Medical & Gene Therapy Officer 20 Aug 2025, 17:00
RCKT ROCKET PHARMACEUTICALS, INC. 14 Aug 2025 1 -$33,695 4 Chief Medical & Gene Therapy Officer 18 Aug 2025, 16:35
RCKT ROCKET PHARMACEUTICALS, INC. 20 May 2025 1 -$5,163 4 Chief Medical & Gene Therapy Officer 22 May 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 16 May 2025 1 -$10,327 4 Chief Medical & Gene Therapy Officer 20 May 2025, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 11 Feb 2025 2 $0 4 Chief Medical & Gene Therapy Officer 13 Feb 2025, 16:01
RCKT ROCKET PHARMACEUTICALS, INC. 17 May 2024 4 -$223,965 4 Chief Medical & Gene Therapy Officer 27 Feb 2025, 16:01
RCKT ROCKET PHARMACEUTICALS, INC. 25 Mar 2024 0 $0 3 Chief Medical & Gene Therapy Officer Exhibit 24: Power of Attorney 03 Apr 2024, 18:07
/report/000141588923015129-schwartz-jonathan-david-2023-11-03 Tabula Rasa HealthCare, Inc. 03 Nov 2023 2 $0 4 Director 14 Nov 2023, 20:59
/report/000141588923009747-schwartz-jonathan-david-2023-06-09 Tabula Rasa HealthCare, Inc. 09 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:33
RCKT ROCKET PHARMACEUTICALS, INC. 17 Feb 2023 1 -$67,796 4 Chief Medical Officer & Clinical Development, SVP 22 Feb 2023, 18:28
RCKT ROCKET PHARMACEUTICALS, INC. 14 Feb 2023 4 $0 4/A Chief Medical Officer & Clinical Development, SVP 22 Feb 2023, 18:25
/report/000141588922009692-schwartz-jonathan-david-2022-09-13 Tabula Rasa HealthCare, Inc. 13 Sep 2022 1 $0 4 Director 15 Sep 2022, 21:06
/report/000141588922009690-schwartz-jonathan-david-2022-09-13 Tabula Rasa HealthCare, Inc. 13 Sep 2022 0 $0 3 Director 15 Sep 2022, 21:05
RCKT ROCKET PHARMACEUTICALS, INC. 12 Aug 2022 1 $0 4 Chief Medical Officer & Clinical Development, SVP 16 Aug 2022, 17:33
RCKT ROCKET PHARMACEUTICALS, INC. 30 Mar 2022 6 -$2,187,740 4/A Chief Medical Officer & Clinical Development, SVP. 04 Apr 2022, 07:37
RCKT ROCKET PHARMACEUTICALS, INC. 14 Feb 2022 2 $0 4 Chief Medical Officer & Clinical Development, SVP. Exhibit 24: Power of Attorney 16 Feb 2022, 20:02